![]() Captor Therapeutics Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases. | Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |||
Founding Date | Founding Date 2013 | Founding Date 2017 | Founding Date 1978 | Founding Date 2008 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations HQ | Locations Wrocław, PL HQ Allschwil, CH | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | |
Employees | Employees 3 | Employees 88 | Employees 16,5612% increase | Employees 5,669 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) | Gross profit ¥383.4b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ₹3.7b (FY, 2026) | Net income ¥67b (FY, 2025) |

Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases.
View company
Biocon is a company that develops and manufactures biopharmaceutical products.
View companyKyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company